Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Finnish company Mobidiag has initiated the development of Novodiag molecular diagnostic test to enable swift diagnosis of the new coronavirus 2019-nCoV and other influenza viruses.

Chinese clinical diagnostics company Autobio Diagnostics and Automobi Molecular Diagnostics, a joint venture (JV) firm of Mobidiag and Autobio, are also part of the initiative.

Novodiag assay will leverage a fully automated ‘sample-in, result-out’ system to the viruses simultaneously in around 30 minutes.

The platform, operated without the need for highly trained personnel, enables delivery to high-risk locations suffering from healthcare staff crisis.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Mobidiag CEO Tuomas Tenkanen said: “It is vital that molecular diagnostics solutions be utilised to fight back against novel coronavirus which has emerged as a significant threat to health across the world.

“Our new Novodiag assay will uniquely offer rapid and fully automated molecular profiling to simultaneously detect novel coronavirus and common influenza strains and guide clinicians more quickly towards moving patients to efficient isolation measures and make better-informed treatment decisions, in situations where time is critical.”

Earlier this week, the UK launched a coronavirus diagnostic test to strengthen its testing capabilities. The launch will help in equipping 12 laboratories to test coronavirus.

Co-Diagnostics and Novacyt’s division Primerdesign also launched research use only (RUO) tests for coronavirus. Subsequently, Co-Diagnostics announced sales of its screening test to various international markets.

Meanwhile, the coronavirus outbreak death toll crossed one thousand, with confirmed cases rising to around 43,000.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact